Teva Likely to Name New CEO This Month

Teva Likely to Name New CEO This Month Play

Jan. 6 (Bloomberg) -- Teva Pharmaceutical is likely to name board member Erez Vigodman as chief executive officer this month and an activist shareholder is urging investors to support the appointment, according to two people with knowledge of the matter. Elliott Gotkine has more on Bloomberg Television's "Countdown." (Source: Bloomberg)

  • On Air Now

    Bloomberg West Watch Now

  • Next

    Money Clip

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus